Latest: FDA Approves New Biosimilar for Oncology Treatment

Unique Psychological Burden of Fear of Progression Seen in MG

08 August, 2025

0 Mins

Fear of progression is common among patients living with chronic diseases, but the degree to which it interferes with patient outcomes, including treatment adherence, deserves further investigation, study authors note.

Tags:

Author

American Journal Managed Care

Patients With Ovarian Cancer, Higher Social Vulnerability Face Delayed Treatment but Earlier Palliative Care Consultations

FDA OKs Intravenous Tocilizumab Biosimilar in Cytokine Release Syndrome

📢

300x250 Banner

Unique Psychological Burden of Fear of Progression Seen in MG

Tags:

American Journal Managed Care

Patients With Ovarian Cancer, Higher Social Vulnerability Face Delayed Treatment but Earlier Palliative Care Consultations

FDA OKs Intravenous Tocilizumab Biosimilar in Cytokine Release Syndrome

Recent Content

COPD Biologics: Early Treatment Insights

Antihypertensive Medication Guidelines

Juvenile Arthritis Care Transition